Đọc thêm Estradiol_(dược_phẩm)

  1. ↑ Susan M. Ford; Sally S. Roach (7 tháng 10 năm 2013). Roach's Introductory Clinical Pharmacology. Lippincott Williams & Wilkins. tr. 525–. ISBN 978-1-4698-3214-2.
  2. ↑ Maryanne Hochadel; Mosby (1 tháng 4 năm 2015). Mosby's Drug Reference for Health Professions. Elsevier Health Sciences. tr. 602–. ISBN 978-0-323-31103-8.
  3. 1 2 3 4 5 6 Stanczyk, Frank Z.; Archer, David F.; Bhavnani, Bhagu R. (2013). “Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment”. Contraception. 87 (6): 706–727. doi:10.1016/j.contraception.2012.12.011. ISSN 0010-7824. PMID 23375353.
  4. 1 2 3 Düsterberg B, Nishino Y (1982). “Pharmacokinetic and pharmacological features of oestradiol valerate”. Maturitas. 4 (4): 315–24. doi:10.1016/0378-5122(82)90064-0. PMID 7169965.
  5. ↑ Tommaso Falcone; William W. Hurd (2007). Clinical Reproductive Medicine and Surgery. Elsevier Health Sciences. tr. 22, 362, 388. ISBN 978-0-323-03309-1.
  6. ↑ Price, T; Blauer, K; Hansen, M; Stanczyk, F; Lobo, R; Bates, G (1997). “Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17-estradiol”. Obstetrics & Gynecology. 89 (3): 340–345. doi:10.1016/S0029-7844(96)00513-3. ISSN 0029-7844. PMID 9052581.
  7. ↑ Naunton, Mark; Al Hadithy, Asmar F. Y.; Brouwers, Jacobus R. B. J.; Archer, David F. (2006). “Estradiol gel”. Menopause. 13 (3): 517–527. doi:10.1097/01.gme.0000191881.52175.8c. ISSN 1072-3714. PMID 16735950.
  8. ↑ Sierra-Ramírez JA, Lara-Ricalde R, Lujan M, Velázquez-Ramírez N, Godínez-Victoria M, Hernádez-Munguía IA, Padilla A, Garza-Flores J (2011). “Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg)”. Contraception. 84 (6): 565–70. doi:10.1016/j.contraception.2011.03.014. PMID 22078184.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
  10. ↑ Michael Oettel; Ekkehard Schillinger (6 tháng 12 năm 2012). Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens. Springer Science & Business Media. tr. 121, 226, 235–237. ISBN 978-3-642-58616-3.
  11. 1 2 3 4 5 6 7 Michael Oettel; Ekkehard Schillinger (6 tháng 12 năm 2012). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen. Springer Science & Business Media. tr. 163–178, 235–237, 252–253, 261–276, 538–543. ISBN 978-3-642-60107-1.
  12. 1 2 3 4 Christin-Maitre S (2017). “Use of Hormone Replacement in Females with Endocrine Disorders”. Horm Res Paediatr. 87 (4): 215–223. doi:10.1159/000457125. PMID 28376481.
  13. 1 2 3 Christin-Maitre S, Laroche E, Bricaire L (tháng 1 năm 2013). “A new contraceptive pill containing 17β-estradiol and nomegestrol acetate”. Womens Health (Lond). 9 (1): 13–23. doi:10.2217/whe.12.70. PMID 23241152.
  14. 1 2 3 4 Newton JR, D'arcangues C, Hall PE (1994). “A review of "once-a-month" combined injectable contraceptives”. J Obstet Gynaecol (Lahore). 4 Suppl 1: S1–34. doi:10.3109/01443619409027641. PMID 12290848.
  15. 1 2 3 Wesp LM, Deutsch MB (2017). “Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons”. Psychiatr. Clin. North Am. 40 (1): 99–111. doi:10.1016/j.psc.2016.10.006. PMID 28159148.
  16. 1 2 Ali Shah SI (2015). “Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer”. South Asian J Cancer. 4 (2): 95–7. doi:10.4103/2278-330X.155699. PMC 4418092. PMID 25992351.
  17. 1 2 3 4 Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen J (tháng 1 năm 2017). “The use of high-dose estrogens for the treatment of breast cancer”. Maturitas. 95: 11–23. doi:10.1016/j.maturitas.2016.10.010. PMID 27889048.
  18. 1 2 3 4 5 6 7 8 9 10 11 Warner Chilcott (tháng 3 năm 2005). “ESTRACE TABLETS, (estradiol tablets, USP)” (PDF). fda.gov. Truy cập ngày 27 tháng 11 năm 2016.
  19. 1 2 Richard P. Pohanish (2011). Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens. William Andrew. tr. 1167–. ISBN 978-1-4377-7869-4.
  20. 1 2 Russell La Fayette Cecil; J. Claude Bennett; Fred Plum (1996). Cecil Textbook of Medicine. Saunders. ISBN 978-0-7216-3575-0. Estrogen excess in men causes inhibition of gonadotropin secretion and secondary hypogonadism. Estrogen excess may result from either exogenous administration of estrogens or estrogenic substances (e.g., diethylstilbestrol administration [...]
  21. ↑ Yang Z, Hu Y, Zhang J, Xu L, Zeng R, Kang D (tháng 2 năm 2017). “Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis”. Gynecol. Endocrinol. 33 (2): 87–92. doi:10.1080/09513590.2016.1248932. PMID 27898258.
  22. ↑ Lambrinoudaki I (tháng 4 năm 2014). “Progestogens in postmenopausal hormone therapy and the risk of breast cancer”. Maturitas. 77 (4): 311–7. doi:10.1016/j.maturitas.2014.01.001. PMID 24485796.
  23. 1 2 3 Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A (1988). “Single drug polyestradiol phosphate therapy in prostatic cancer”. Am. J. Clin. Oncol. 11 Suppl 2: S101–3. doi:10.1097/00000421-198801102-00024. PMID 3242384.
  24. 1 2 3 Ockrim JL, Lalani EN, Laniado ME, Carter SS, Abel PD (tháng 5 năm 2003). “Transdermal estradiol therapy for advanced prostate cancer--forward to the past?”. J. Urol. 169 (5): 1735–7. doi:10.1097/01.ju.0000061024.75334.40. PMID 12686820.
  25. 1 2 3 4 Fritz F. Parl (2000). Estrogens, Estrogen Receptor and Breast Cancer. IOS Press. tr. 4, 111. ISBN 978-0-9673355-4-4.
  26. 1 2 3 Christian Lauritzen; John W. W. Studd (22 tháng 6 năm 2005). Current Management of the Menopause. CRC Press. tr. 44, 95–98, 488. ISBN 978-0-203-48612-2.
  27. 1 2 Kaufman, C. (1933). “Die Behandlung der Amenorrhöe mit Hohen Dosen der Ovarialhormone”. Klinische Wochenschrift. 12 (40): 1557–1562. doi:10.1007/BF01765673. ISSN 0023-2173.
  28. 1 2 Buschbeck, Herbert (2009). “Neue Wege der Hormontherapie in der Gynäkologie” [New ways of hormonal therapy in gynecology]. Deutsche Medizinische Wochenschrift. 60 (11): 389–393. doi:10.1055/s-0028-1129842. ISSN 0012-0472.
  29. 1 2 3 Biskind, Morton S. (1935). “Commercial Glandular Products”. Journal of the American Medical Association. 105 (9): 667. doi:10.1001/jama.1935.92760350007009a. ISSN 0002-9955. Progynon-B, Schering Corporation: This is crystalline hydroxyestrin benzoate obtained by hydrogenation of theelin and subsequent conversion to the benzoate. [...] Progynon-B is marketed in ampules containing 1 cc. of a sesame oil solution of hydroxyestrin benzoate of either 2,500, 5,000, 10,000 or 50,000 international units.
  30. 1 2 “Neue Spezialitäten”. Klinische Wochenschrift. 44 (23): 1381. 1966. doi:10.1007/BF01747900. ISSN 0023-2173. NEUE SPEZIALITATEN [...] Progynova. 1 Dragee enthält 2 mg Oestradiolvalerinat (Klimakterium). Hersteller: Schering AG, Berlin 65.
  31. 1 2 Dapunt O (tháng 9 năm 1967). “Behandlung klimakterischer Beschwerden mit Östradiolvalerianat (Progynova)” [The management of climacteric disorders using estradiol valerate (Progynova)]. Med Klin (bằng tiếng Đức). 62 (35): 1356–61 passim. ISSN 0025-8458. PMID 5593020.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  32. 1 2 3 4 http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&ApplNo=084499&DrugName=ESTRACE&ActiveIngred=ESTRADIOL&SponsorApplicant=BRISTOL%20MYERS%20SQUIBB&ProductMktStatus=3&goto=Search.DrugDetails
  33. 1 2 3 “The Top 300 of 2019”. clincalc.com. Truy cập ngày 22 tháng 12 năm 2018.
  34. ↑ Mutschler, Ernst; Schäfer-Korting, Monika (2001). Arzneimittelwirkungen (bằng tiếng Đức) (ấn bản 8). Stuttgart: Wissenschaftliche Verlagsgesellschaft. tr. 434, 444. ISBN 978-3-8047-1763-3.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  35. ↑ Whedon JM, KizhakkeVeettil A, Rugo NA, Kieffer KA (tháng 1 năm 2017). “Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis”. J Womens Health (Larchmt). 26 (1): 18–28. doi:10.1089/jwh.2015.5628. PMID 27603786.
  36. ↑ Matthews D, Bath L, Högler W, Mason A, Smyth A, Skae M (tháng 10 năm 2017). “Hormone supplementation for pubertal induction in girls” (PDF). Arch. Dis. Child. 102 (10): 975–980. doi:10.1136/archdischild-2016-311372. PMID 28446424.
  37. 1 2 3 Laura Rosenthal; Jacqueline Burchum (17 tháng 2 năm 2017). Lehne's Pharmacotherapeutics for Advanced Practice Providers - E-Book. Elsevier Health Sciences. tr. 524–. ISBN 978-0-323-44779-9.
  38. 1 2 Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, Seventh Version
  39. ↑ Evans G, Sutton EL (tháng 5 năm 2015). “Oral contraception”. Med Clin North Am. 99 (3): 479–503. doi:10.1016/j.mcna.2015.01.004. PMID 25841596.
  40. ↑ Glasier, Anna (2010). “Contraception”. Trong Jameson, J. Larry; De Groot, Leslie J. (biên tập). Endocrinology (ấn bản 6). Philadelphia: Saunders Elsevier. tr. 2417–2427. ISBN 978-1-4160-5583-9.
  41. 1 2 3 4 5 6 Lycette JL, Bland LB, Garzotto M, Beer TM (2006). “Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?”. Clin Genitourin Cancer. 5 (3): 198–205. doi:10.3816/CGC.2006.n.037. PMID 17239273.
  42. ↑ Cox RL, Crawford ED (1995). “Estrogens in the treatment of prostate cancer”. J. Urol. 154 (6): 1991–8. doi:10.1016/S0022-5347(01)66670-9. PMID 7500443.
  43. ↑ Altwein, J. (1983). “Controversial Aspects of Hormone Manipulation in Prostatic Carcinoma”. Cancer of the Prostate and Kidney. tr. 305–316. doi:10.1007/978-1-4684-4349-3_38. ISBN 978-1-4684-4351-6.
  44. ↑ Ockrim JL; Lalani el-N; Kakkar AK; Abel PD (tháng 8 năm 2005). “Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism”. J. Urol. 174 (2): 527–33, discussion 532–3. doi:10.1097/01.ju.0000165567.99142.1f. PMID 16006886.
  45. 1 2 3 4 5 Waun Ki Hong; James F. Holland (2010). Holland-Frei Cancer Medicine 8. PMPH-USA. tr. 753–. ISBN 978-1-60795-014-1.
  46. 1 2 3 4 Scherr DS, Pitts WR (2003). “The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer”. J. Urol. 170 (5): 1703–8. doi:10.1097/01.ju.0000077558.48257.3d. PMID 14532759.
  47. 1 2 3 Coss, Christopher C.; Jones, Amanda; Parke, Deanna N.; Narayanan, Ramesh; Barrett, Christina M.; Kearbey, Jeffrey D.; Veverka, Karen A.; Miller, Duane D.; Morton, Ronald A. (2012). “Preclinical Characterization of a Novel Diphenyl Benzamide Selective ERα Agonist for Hormone Therapy in Prostate Cancer”. Endocrinology. 153 (3): 1070–1081. doi:10.1210/en.2011-1608. ISSN 0013-7227. PMID 22294742.
  48. ↑ von Schoultz B, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A, Stege R (1989). “Estrogen therapy and liver function--metabolic effects of oral and parenteral administration”. Prostate. 14 (4): 389–95. doi:10.1002/pros.2990140410. PMID 2664738.
  49. 1 2 Ockrim J, Lalani EN, Abel P (tháng 10 năm 2006). “Therapy Insight: parenteral estrogen treatment for prostate cancer--a new dawn for an old therapy”. Nat Clin Pract Oncol. 3 (10): 552–63. doi:10.1038/ncponc0602. PMID 17019433.
  50. ↑ Wibowo E, Schellhammer P, Wassersug RJ (2011). “Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy”. J. Urol. 185 (1): 17–23. doi:10.1016/j.juro.2010.08.094. PMID 21074215.
  51. 1 2 3 John A. Thomas; Edward J. Keenan (6 tháng 12 năm 2012). Principles of Endocrine Pharmacology. Springer Science & Business Media. tr. 148–. ISBN 978-1-4684-5036-1.
  52. ↑ William R. Miller; James N. Ingle (8 tháng 3 năm 2002). Endocrine Therapy in Breast Cancer. CRC Press. tr. 49–52. ISBN 978-0-203-90983-6.
  53. ↑ Ellis, MJ; Dehdahti, F; Kommareddy, A; Jamalabadi-Majidi, S; Crowder, R; Jeffe, DB; Gao, F; Fleming, G; Silverman, P (2014). “A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer”. Cancer Research. 69 (2 Supplement): 16. doi:10.1158/0008-5472.SABCS-16. ISSN 0008-5472.
  54. ↑ Palmieri C, Patten DK, Januszewski A, Zucchini G, Howell SJ (tháng 1 năm 2014). “Breast cancer: current and future endocrine therapies”. Mol. Cell. Endocrinol. 382 (1): 695–723. doi:10.1016/j.mce.2013.08.001. PMID 23933149.
  55. ↑ “Bản sao đã lưu trữ”. Bản gốc lưu trữ ngày 2 tháng 1 năm 2018. Truy cập ngày 22 tháng 8 năm 2019.
  56. ↑ Ostrowski MJ, Jackson AW (1979). “Polyestradiol phosphate: a preliminary evaluation of its effect on breast carcinoma”. Cancer Treat Rep. 63 (11–12): 1803–7. PMID 393380.
  57. ↑ J. Aiman (6 tháng 12 năm 2012). Infertility: Diagnosis and Management. Springer Science & Business Media. tr. 133–134. ISBN 978-1-4613-8265-2.
  58. ↑ Glenn L. Schattman; Sandro Esteves; Ashok Agarwal (12 tháng 5 năm 2015). Unexplained Infertility: Pathophysiology, Evaluation and Treatment. Springer. tr. 266–. ISBN 978-1-4939-2140-9.
  59. 1 2 Pinheiro, Lanna Marla Andrade; Cândido, Priscilla da Silva; Moreto, Tássia Camila; Almeida, Wanessa Gonzaga Di; de Castro, Eduardo Camelo (2017). “Estradiol use in the luteal phase and its effects on pregnancy rates in IVF cycles with GnRH antagonist: a systematic review”. JBRA Assisted Reproduction. 21 (3): 247–250. doi:10.5935/1518-0557.20170046. ISSN 1517-5693. PMC 5574648. PMID 28837035.
  60. ↑ A. Labhart (6 tháng 12 năm 2012). Clinical Endocrinology: Theory and Practice. Springer Science & Business Media. tr. 512, 696. ISBN 978-3-642-96158-8.
  61. 1 2 Juul A (2001). “The effects of oestrogens on linear bone growth”. Hum. Reprod. Update. 7 (3): 303–13. doi:10.1093/humupd/7.3.303. PMID 11392377.
  62. ↑ Albuquerque EV, Scalco RC, Jorge AA (2017). “Management of Endocrine Disease: Diagnostic and therapeutic approach of tall stature”. Eur. J. Endocrinol. 176 (6): R339–R353. doi:10.1530/EJE-16-1054. PMID 28274950.
  63. ↑ Upners EN, Juul A (2016). “Evaluation and phenotypic characteristics of 293 Danish girls with tall stature: effects of oral administration of natural 17β-estradiol”. Pediatr. Res. 80 (5): 693–701. doi:10.1038/pr.2016.128. PMID 27410906.
  64. 1 2 3 4 Gunther Göretzlehner; Christian Lauritzen; Thomas Römer; Winfried Rossmanith (1 tháng 1 năm 2012). Praktische Hormontherapie in der Gynäkologie. Walter de Gruyter. tr. 385–. ISBN 978-3-11-024568-4.
  65. 1 2 R.E. Mansel; Oystein Fodstad; Wen G. Jiang (14 tháng 6 năm 2007). Metastasis of Breast Cancer. Springer Science & Business Media. tr. 217–. ISBN 978-1-4020-5866-0.
  66. 1 2 3 4 Hartmann BW, Laml T, Kirchengast S, Albrecht AE, Huber JC (1998). “Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I”. Gynecol. Endocrinol. 12 (2): 123–7. doi:10.3109/09513599809024960. PMID 9610425.
  67. 1 2 3 4 Lauritzen, C (1980). “Hormonkur kann hypoplastischer Mamma aufhelfen”. Selecta (bằng tiếng Đức) (43): 3798–3801.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  68. ↑ Kaiser, Rolf; Leidenberger, Freimut A. (1991). Hormonbehandlung in der gynäkologischen Praxis (ấn bản 6). Stuttgart, New York: Georg Thieme Verlag. tr. 138–139. ISBN 978-3133574075.
  69. 1 2 3 Begemann MJ, Dekker CF, van Lunenburg M, Sommer IE (tháng 11 năm 2012). “Estrogen augmentation in schizophrenia: a quantitative review of current evidence”. Schizophr. Res. 141 (2–3): 179–84. doi:10.1016/j.schres.2012.08.016. PMID 22998932.
  70. 1 2 Kulkarni J, Gavrilidis E, Wang W, Worsley R, Fitzgerald PB, Gurvich C, Van Rheenen T, Berk M, Burger H (tháng 6 năm 2015). “Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age”. Mol. Psychiatry. 20 (6): 695–702. doi:10.1038/mp.2014.33. PMID 24732671.
  71. 1 2 Brzezinski A, Brzezinski-Sinai NA, Seeman MV (tháng 5 năm 2017). “Treating schizophrenia during menopause”. Menopause. 24 (5): 582–588. doi:10.1097/GME.0000000000000772. PMID 27824682.
  72. ↑ McGregor C, Riordan A, Thornton J (tháng 10 năm 2017). “Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms”. Front Neuroendocrinol. 47: 19–33. doi:10.1016/j.yfrne.2017.06.003. PMID 28673758.
  73. 1 2 de Boer J, Prikken M, Lei WU, Begemann M, Sommer I (tháng 1 năm 2018). “The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis”. NPJ Schizophr. 4 (1): 1. doi:10.1038/s41537-017-0043-3. PMC 5762671. PMID 29321530.
  74. 1 2 Khan MM (tháng 7 năm 2016). “Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia”. CNS Drugs. 30 (7): 589–601. doi:10.1007/s40263-016-0343-6. PMID 27193386.
  75. 1 2 Kulkarni J, Gavrilidis E, Worsley R, Van Rheenen T, Hayes E (2013). “The role of estrogen in the treatment of men with schizophrenia”. Int J Endocrinol Metab. 11 (3): 129–36. doi:10.5812/ijem.6615. PMC 3860106. PMID 24348584.
  76. ↑ Owens SJ, Murphy CE, Purves-Tyson TD, Weickert TW, Shannon Weickert C (tháng 2 năm 2018). “Considering the role of adolescent sex steroids in schizophrenia”. J. Neuroendocrinol. 30 (2): e12538. doi:10.1111/jne.12538. PMID 28941299.
  77. 1 2 Guay, David R.P. (2009). “Drug treatment of paraphilic and nonparaphilic sexual disorders”. Clinical Therapeutics. 31 (1): 1–31. doi:10.1016/j.clinthera.2009.01.009. ISSN 0149-2918. PMID 19243704.
  78. 1 2 Howard Gethin Morgan; Margaret Hilary Morgan (1984). Aids to Psychiatry. Churchill Livingstone. tr. 75. ISBN 978-0-443-02613-3. Treatment of sexual offenders. Hormone therapy. [...] Oestrogens may cause breast hypertrophy, testicular atrophy, osteoporosis (oral ethinyl oestradiol 0.01-0.05 mg/day causes least nausea). Depot preparation: oestradiol [undecyleate] 50-100mg once every 3–4 weeks. Benperidol or butyrophenone and the antiandrogen cyproterone acetate also used.
  79. 1 2 Thomas L. Lemke; David A. Williams (24 tháng 1 năm 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. tr. 1419–. ISBN 978-1-60913-345-0.
  80. 1 2 3 4 Mikkola A, Ruutu M, Aro J, Rannikko S, Salo J (1999). “The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium”. Ann Chir Gynaecol. 88 (1): 18–21. PMID 10230677.
  81. 1 2 3 Lauritzen C (tháng 9 năm 1990). “Clinical use of oestrogens and progestogens”. Maturitas. 12 (3): 199–214. doi:10.1016/0378-5122(90)90004-P. PMID 2215269.
  82. ↑ Laurtizen, Christian (2001). “Hormone Substitution Before, During and After Menopause” (PDF). Trong Fisch, Franz H. (biên tập). Menopause – Andropause: Hormone Replacement Therapy Through the Ages. Krause & Pachernegg: Gablitz. tr. 67–88. ISBN 978-3-901299-34-6.
  83. ↑ Midwinter, Audrey (1976). “Contraindications to estrogen therapy and management of the menopausal syndrome in these cases”. Trong Campbell, Stuart (biên tập). The Management of the Menopause & Post-Menopausal Years: The Proceedings of the International Symposium held in London 24–26 November 1975 Arranged by the Institute of Obstetrics and Gynaecology, The University of London. MTP Press Limited. tr. 377–382. doi:10.1007/978-94-011-6165-7_33. ISBN 978-94-011-6167-1.
  84. ↑ Pfizer (tháng 8 năm 2008). “ESTRING (estradiol vaginal ring)” (PDF).
  85. 1 2 L'hermite M, Simoncini T, Fuller S, Genazzani AR (2008). “Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review”. Maturitas. 60 (3–4): 185–201. doi:10.1016/j.maturitas.2008.07.007. PMID 18775609.
  86. 1 2 Holtorf K (tháng 1 năm 2009). “The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?”. Postgrad Med. 121 (1): 73–85. doi:10.3810/pgm.2009.01.1949. PMID 19179815.
  87. 1 2 Conaway E (tháng 3 năm 2011). “Bioidentical hormones: an evidence-based review for primary care providers”. J Am Osteopath Assoc. 111 (3): 153–64. PMID 21464264.
  88. 1 2 Simon JA (tháng 4 năm 2012). “What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone”. Climacteric. 15 Suppl 1: 3–10. doi:10.3109/13697137.2012.669332. PMID 22432810.
  89. 1 2 Mueck AO (tháng 4 năm 2012). “Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone”. Climacteric. 15 Suppl 1: 11–7. doi:10.3109/13697137.2012.669624. PMID 22432811.
  90. 1 2 L'Hermite M (tháng 8 năm 2013). “HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT”. Climacteric. 16 Suppl 1: 44–53. doi:10.3109/13697137.2013.808563. PMID 23848491.
  91. 1 2 Simon JA (tháng 7 năm 2014). “What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?”. Menopause. 21 (7): 769–83. doi:10.1097/GME.0000000000000169. PMID 24398406.
  92. 1 2 L'Hermite M (tháng 8 năm 2017). “Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal”. Climacteric. 20 (4): 331–338. doi:10.1080/13697137.2017.1291607. PMID 28301216.
  93. 1 2 Davey DA (tháng 3 năm 2018). “Menopausal hormone therapy: a better and safer future”. Climacteric. 21 (5): 454–461. doi:10.1080/13697137.2018.1439915. PMID 29526116.
  94. 1 2 Kenneth L. Becker (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. tr. 889, 1059–1060, 2153. ISBN 978-0-7817-1750-2.
  95. ↑ http://www.ilexmedical.com/files/PDF/Estradiol_ARC.pdf
  96. ↑ Roger Smith (Prof.) (1 tháng 1 năm 2001). The Endocrinology of Parturition: Basic Science and Clinical Application. Karger Medical and Scientific Publishers. tr. 89–. ISBN 978-3-8055-7195-1.
  97. ↑ Cheng ZN, Shu Y, Liu ZQ, Wang LS, Ou-Yang DS, Zhou HH (tháng 2 năm 2001). “Role of cytochrome P450 in estradiol metabolism in vitro”. Acta Pharmacol. Sin. 22 (2): 148–54. PMID 11741520.
  98. ↑ Schubert W, Cullberg G, Edgar B, Hedner T (tháng 12 năm 1994). “Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women”. Maturitas. 20 (2–3): 155–63. doi:10.1016/0378-5122(94)90012-4. PMID 7715468.
  99. ↑ Hormones, Brain and Behavior. Elsevier. 18 tháng 6 năm 2002. tr. 759–761. ISBN 978-0-08-053415-2.
  100. 1 2 Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M, Gao X, Sholar JW (tháng 12 năm 1996). “Effects of alcohol ingestion on estrogens in postmenopausal women”. JAMA. 276 (21): 1747–51. doi:10.1001/jama.1996.03540210055034. PMID 8940324.
  101. 1 2 Sarkola T, Mäkisalo H, Fukunaga T, Eriksson CJ (tháng 6 năm 1999). “Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women” (PDF). Alcohol. Clin. Exp. Res. 23 (6): 976–82. doi:10.1111/j.1530-0277.1999.tb04215.x. PMID 10397281.
  102. ↑ Leinung MC, Feustel PJ, Joseph J (2018). “Hormonal Treatment of Transgender Women with Oral Estradiol”. Transgend Health. 3 (1): 74–81. doi:10.1089/trgh.2017.0035. PMC 5944393. PMID 29756046.
  103. ↑ Soltysik K, Czekaj P (tháng 4 năm 2013). “Membrane estrogen receptors - is it an alternative way of estrogen action?”. J. Physiol. Pharmacol. 64 (2): 129–42. PMID 23756388.
  104. ↑ Prossnitz ER, Barton M (tháng 5 năm 2014). “Estrogen biology: New insights into GPER function and clinical opportunities”. Mol. Cell. Endocrinol. 389 (1–2): 71–83. doi:10.1016/j.mce.2014.02.002. PMC 4040308. PMID 24530924.
  105. ↑ Ojasoo T, Raynaud JP (tháng 11 năm 1978). “Unique steroid congeners for receptor studies”. Cancer Res. 38 (11 Pt 2): 4186–98. PMID 359134.
  106. ↑ Ojasoo T, Delettré J, Mornon JP, Turpin-VanDycke C, Raynaud JP (1987). “Towards the mapping of the progesterone and androgen receptors”. J. Steroid Biochem. 27 (1–3): 255–69. doi:10.1016/0022-4731(87)90317-7. PMID 3695484.
  107. ↑ Raynaud JP, Bouton MM, Moguilewsky M, Ojasoo T, Philibert D, Beck G, Labrie F, Mornon JP (tháng 1 năm 1980). “Steroid hormone receptors and pharmacology”. J. Steroid Biochem. 12: 143–57. doi:10.1016/0022-4731(80)90264-2. PMID 7421203.
  108. 1 2 A. Labhart (6 tháng 12 năm 2012). Clinical Endocrinology: Theory and Practice. Springer Science & Business Media. tr. 548–. ISBN 978-3-642-96158-8.
  109. ↑ Jennifer E. Dietrich (18 tháng 6 năm 2014). Female Puberty: A Comprehensive Guide for Clinicians. Springer. tr. 53–. ISBN 978-1-4939-0912-4.
  110. ↑ Randy Thornhill; Steven W. Gangestad (25 tháng 9 năm 2008). The Evolutionary Biology of Human Female Sexuality. Oxford University Press. tr. 145–. ISBN 978-0-19-988770-5.
  111. ↑ Raine-Fenning NJ, Brincat MP, Muscat-Baron Y (2003). “Skin aging and menopause: implications for treatment”. Am J Clin Dermatol. 4 (6): 371–8. doi:10.2165/00128071-200304060-00001. PMID 12762829.
  112. ↑ Chris Hayward (31 tháng 7 năm 2003). Gender Differences at Puberty. Cambridge University Press. tr. 22–. ISBN 978-0-521-00165-6.
  113. 1 2 Shlomo Melmed; Kenneth S. Polonsky; P. Reed Larsen; Henry M. Kronenberg (11 tháng 11 năm 2015). Williams Textbook of Endocrinology. Elsevier Health Sciences. tr. 1105–. ISBN 978-0-323-34157-8.
  114. 1 2 3 Richard E. Jones; Kristin H. Lopez (28 tháng 9 năm 2013). Human Reproductive Biology. Academic Press. tr. 19–. ISBN 978-0-12-382185-0.
  115. 1 2 Ethel Sloane (2002). Biology of Women. Cengage Learning. tr. 496–. ISBN 978-0-7668-1142-3.
  116. 1 2 Tekoa L. King; Mary C. Brucker (25 tháng 10 năm 2010). Pharmacology for Women's Health. Jones & Bartlett Learning. tr. 1022–. ISBN 978-0-7637-5329-0.
  117. 1 2 3 Rogerio A. Lobo (5 tháng 6 năm 2007). Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Academic Press. tr. 177, 217–226, 770–771. ISBN 978-0-08-055309-2.
  118. 1 2 David Warshawsky; Joseph R. Landolph Jr. (31 tháng 10 năm 2005). Molecular Carcinogenesis and the Molecular Biology of Human Cancer. CRC Press. tr. 457–. ISBN 978-0-203-50343-0.
  119. ↑ M. Notelovitz; P.A. van Keep (6 tháng 12 năm 2012). The Climacteric in Perspective: Proceedings of the Fourth International Congress on the Menopause, held at Lake Buena Vista, Florida, October 28–November 2, 1984. Springer Science & Business Media. tr. 397, 399. ISBN 978-94-009-4145-8. [...] following the menopause, circulating estradiol levels decrease from a premenopausal mean of 120 pg/ml to only 13 pg/ml.
  120. ↑ C. Christian; B. von Schoultz (15 tháng 3 năm 1994). Hormone Replacement Therapy: Standardized or Individually Adapted Doses?. CRC Press. tr. 9–16, 60. ISBN 978-1-85070-545-1. The mean integrated estradiol level during a full 28-day normal cycle is around 80 pg/ml.
  121. ↑ Eugenio E. Müller; Robert M. MacLeod (6 tháng 12 năm 2012). Neuroendocrine Perspectives. Springer Science & Business Media. tr. 121–. ISBN 978-1-4612-3554-5. [...] [premenopausal] mean [estradiol] concentration of 150 pg/ml [...]
  122. 1 2 3 4 Botros R M B Rizk; Hassan N Sallam (15 tháng 6 năm 2012). Clinical Infertility and In Vitro Fertilization. JP Medical Ltd. tr. 11–. ISBN 978-93-5025-095-2.
  123. 1 2 3 4 5 6 7 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 897–. ISBN 978-1-4757-2085-3.
  124. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. tr. 404–406. ISBN 978-3-88763-075-1. Truy cập ngày 13 tháng 9 năm 2012.
  125. 1 2 3 Fluhmann CF (1938). “Estrogenic Hormones: Their Clinical Usage”. Cal West Med. 49 (5): 362–6. PMC 1659459. PMID 18744783.
  126. ↑ James R. Givens; Garland D. Anderson (1981). Endocrinology of Pregnancy: Based on the Proceedings of the Fifth Annual Symposium on Gynecologic Endocrinology, Held March 3-5, 1980 at the University of Tennessee, Memphis, Tennessee. Year Book Medical Publishers. tr. 158. ISBN 978-0-8151-3529-6. Estetrol (E4) is an estrogen with four hydroxyl groups. More specifically, E4, is 15α-hydroxyestriol.
  127. ↑ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research On Cancer (2007). Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy. World Health Organization. tr. 384. ISBN 978-92-832-1291-1. Truy cập ngày 13 tháng 9 năm 2012.
  128. 1 2 Archana Desai; Mary Lee (7 tháng 5 năm 2007). Gibaldi's Drug Delivery Systems in Pharmaceutical Care. ASHP. tr. 337. ISBN 978-1-58528-136-7. Truy cập ngày 13 tháng 9 năm 2012.
  129. ↑ Rebekah Wang-Cheng; Joan M. Neuner; Vanessa M. Barnabei (2007). Menopause. ACP Press. tr. 91–. ISBN 978-1-930513-83-9.
  130. 1 2 3 4 5 6 7 8 9 “Drugs@FDA: FDA Approved Drug Products”. United States Food and Drug Administration. Truy cập ngày 26 tháng 7 năm 2018.
  131. ↑ Mary Lee; Archana Desai (2007). Gibaldi's Drug Delivery Systems in Pharmaceutical Care. ASHP. tr. 336–. ISBN 978-1-58528-136-7.
  132. ↑ Nursing2013 Drug Handbook. Lippincott Williams & Wilkins. 2012. tr. 528–. ISBN 978-1-4511-5023-0.
  133. ↑ Vermeulen A (1975). “Longacting steroid preparations”. Acta Clin Belg. 30 (1): 48–55. doi:10.1080/17843286.1975.11716973. PMID 1231448.
  134. ↑ Ravery V, Fizazi K, Oudard S, Drouet L, Eymard JC, Culine S, Gravis G, Hennequin C, Zerbib M (tháng 12 năm 2011). “The use of estramustine phosphate in the modern management of advanced prostate cancer”. BJU Int. 108 (11): 1782–6. doi:10.1111/j.1464-410X.2011.10201.x. PMID 21756277.
  135. ↑ Hubert Vaudry; Olivier Kah (25 tháng 1 năm 2018). Trends in Comparative Endocrinology and Neurobiology. Frontiers Media SA. tr. 115–. ISBN 978-2-88945-399-3.
  136. ↑ Shoupe D, Haseltine FP (6 tháng 12 năm 2012). Contraception. Springer Science & Business Media. tr. 2–. ISBN 978-1-4612-2730-4.
  137. 1 2 Reilly WA (1941). “Estrogens: Their Use in Pediatrics”. Cal West Med. 55 (5): 237–9. PMC 1634235. PMID 18746057.
  138. 1 2 Novak, Emil (1935). “The Therapeutic Use of Estrogenic Substances”. JAMA: The Journal of the American Medical Association. 104 (20): 1815. doi:10.1001/jama.1935.92760200002012. ISSN 0098-7484. Progynon B (Schering), in 1 cc. ampules, of 10,000 or 50,000 international units of hydroxyestrin benzoate in sesame oil.
  139. ↑ Macpherson AS (tháng 6 năm 1940). “The Use of Œstrogens in Obstetrics and Gynæcology”. Edinb Med J. 47 (6): 406–424. PMC 5306594. PMID 29646930.
  140. ↑ “NNR: Products Recently Accepted by the A. M. A. Council on Pharmacy and Chemistry”. Journal of the American Pharmaceutical Association (Practical Pharmacy Ed.). 10 (11): 692–694. 1949. doi:10.1016/S0095-9561(16)31995-8. ISSN 0095-9561.
  141. 1 2 3 Martin PL, Burnier AM, Greaney MO (1972). “Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference”. Obstet Gynecol. 39 (5): 771–4. PMID 5023261.
  142. ↑ Velikay L (tháng 3 năm 1968). “Die perorale Behandlung des klimakterischen Syndroms mit Ostradiolvalerianat” [The peroral treatment of the climacteric syndrome with estradiol valerate]. Wien. Klin. Wochenschr. (bằng tiếng Đức). 80 (12): 229–33. ISSN 0043-5325. PMID 5728263.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  143. ↑ Koed J (tháng 5 năm 1972). “Zur Behandlung klimakterischer Ausfallserscheinungen mit Progynova” [Therapy of climacteric deficiency symptoms using Progynova]. Med Welt (bằng tiếng Đức). 23 (22): 834–6. ISSN 0025-8512. PMID 5045321.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  144. ↑ Rigg LA, Milanes B, Villanueva B, Yen SS (1977). “Efficacy of intravaginal and intranasal administration of micronized estradiol-17beta”. J. Clin. Endocrinol. Metab. 45 (6): 1261–4. doi:10.1210/jcem-45-6-1261. PMID 591620.
  145. 1 2 3 4 5 Yoo JW, Lee CH (tháng 5 năm 2006). “Drug delivery systems for hormone therapy”. J Control Release. 112 (1): 1–14. doi:10.1016/j.jconrel.2006.01.021. PMID 16530874. Transdermal gels. The first system used for estrogen delivery through skin was the application of estrogen dissolved into a water–alcohol solvent in a form of gel for the treatment of postmenopausal symptoms [80] [...] EstroGel® (Solvay) has been in the Europe market for more than 25 years, but approved in the U.S. only in 2004. EstroGel® contains 17β-estradiol in a hydro-alcoholic gel base which renders a controlled release profile. [...] Estrasorb® (Novavax, Malvern, PA) is launched in 2003 as the first topical, lotion-like nanoemulsion for the treatment of vasomotor symptoms. [...] Conventional reservoir patches. The first transdermal patch for HT was Estraderm® (Novartis, Switzerland) which was launched in Europe in 1985 and has been widely used ever since. [...] Transdermal matrix patches. [...] Climara® (Berlex, Montville, NJ) was first introduced as the matrix patch in 1995. A year later, Vivelle® (Novogyne, Miami, FL) was introduced in the market [...]
  146. ↑ Davis SR, Dinatale I, Rivera-Woll L, Davison S (tháng 5 năm 2005). “Postmenopausal hormone therapy: from monkey glands to transdermal patches”. J. Endocrinol. 185 (2): 207–22. doi:10.1677/joe.1.05847. PMID 15845914. One of the earliest reports of the novel transdermal patch delivery system for oestradiol was published in 1983 (Laufer et al. 1983).
  147. ↑ Benson, Heather A. E.; Watkinson, Adam C. (2011). Transdermal and Topical Drug Delivery Today. doi:10.1002/9781118140505. ISBN 9781118140505. Table 18.1 Passive Transdermal Drugs for Systemic Drug Delivery Launched in the United States and Europe [...] Drug: Estradiol. Indication: Female HRT. U.S. approval: 1986. Marketed in the EU: Yes.
  148. ↑ Prausnitz MR, Mitragotri S, Langer R (tháng 2 năm 2004). “Current status and future potential of transdermal drug delivery”. Nat Rev Drug Discov. 3 (2): 115–24. doi:10.1038/nrd1304. PMID 15040576. Timeline: Important events in transdermal drug delivery: [...] 1986: Estraderm (17β-oestradiol) patch, FDA approval for hormone replacement.
  149. ↑ Pastore MN, Kalia YN, Horstmann M, Roberts MS (tháng 5 năm 2015). “Transdermal patches: history, development and pharmacology”. Br. J. Pharmacol. 172 (9): 2179–209. doi:10.1111/bph.13059. PMC 4403087. PMID 25560046.
  150. ↑ Walter Sneader (23 tháng 6 năm 2005). Drug Discovery: A History. John Wiley & Sons. tr. 195–. ISBN 978-0-471-89979-2.
  151. ↑ Oriowo MA, Landgren BM, Stenström B, Diczfalusy E (1980). “A comparison of the pharmacokinetic properties of three estradiol esters”. Contraception. 21 (4): 415–24. doi:10.1016/s0010-7824(80)80018-7. PMID 7389356.
  152. 1 2 Michael Oettel; Ekkehard Schillinger (6 tháng 12 năm 2012). Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens. Springer Science & Business Media. tr. 7–8. ISBN 978-3-642-58616-3.
  153. ↑ Mosby's GenRx: A Comprehensive Reference for Generic and Brand Prescription Drugs. Mosby. 2001. tr. 944. ISBN 978-0-323-00629-3.
  154. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 https://www.drugs.com/international/estradiol.html
  155. 1 2 I.K. Morton; Judith M. Hall (6 tháng 12 năm 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. tr. 206–. ISBN 978-94-011-4439-1.
  156. ↑ http://www.kegg.jp/entry/D00105
  157. ↑ http://www.wjpps.com/download/article/1412071798.pdf
  158. ↑ Rowlands, S (2009). “New technologies in contraception”. BJOG: An International Journal of Obstetrics & Gynaecology. 116 (2): 230–239. doi:10.1111/j.1471-0528.2008.01985.x. ISSN 1470-0328. PMID 19076955.
  159. ↑ Sweetman, Sean C. biên tập (2009). “Sex hormones and their modulators”. Martindale: The Complete Drug Reference (ấn bản 36). London: Pharmaceutical Press. tr. 2097. ISBN 978-0-85369-840-1.
  160. ↑ http://www.micromedexsolutions.com
  161. ↑ http://adisinsight.springer.com/drugs/800038089
  162. ↑ Pickar JH, Bon C, Amadio JM, Mirkin S, Bernick B (2015). “Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy”. Menopause. 22 (12): 1308–16. doi:10.1097/GME.0000000000000467. PMC 4666011. PMID 25944519.
  163. ↑ Kaunitz AM, Kaunitz JD (2015). “Compounded bioidentical hormone therapy: time for a reality check?”. Menopause. 22 (9): 919–20. doi:10.1097/GME.0000000000000484. PMID 26035149.
  164. 1 2 Pinkerton JV, Pickar JH (tháng 2 năm 2016). “Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy”. Menopause. 23 (2): 215–23. doi:10.1097/GME.0000000000000523. PMC 4927324. PMID 26418479.
  165. ↑ Fugh-Berman A, Bythrow J (2007). “Bioidentical hormones for menopausal hormone therapy: variation on a theme”. J Gen Intern Med. 22 (7): 1030–4. doi:10.1007/s11606-007-0141-4. PMC 2219716. PMID 17549577.
  166. ↑ Catriona Melville (22 tháng 9 năm 2015). Sexual and Reproductive Health at a Glance. Wiley. tr. 108–. ISBN 978-1-119-23516-3.
  167. ↑ Colin T. Dollery (1991). Therapeutic Drugs. Churchill Livingstone. Parenteral preparations 1. Oestradiol implants (Organon, UK) are sterilized pellets containing 25, 50 or 100 mg. They are supplied individually in glass tubes.
  168. ↑ Ashutosh Kar (2005). Medicinal Chemistry. New Age International. tr. 614–. ISBN 978-81-224-1565-0. Oestradiol Implants(R) (Organon, U.K.). Dose. [...] implantation, 20 to 100 mg.
  169. ↑ William A. W. Walters (10 tháng 7 năm 1986). Transsexualism and sex reassignment. Oxford University Press. tr. 159. ISBN 978-0-19-554462-6. 2. Injections or implants [...] Oestradiol Implants (Organon) 20 mg pellets. 50 mg pellets. 100 mg pellets.
  170. ↑ Wiebe J. Braam (2006). Broze botten. Inmerc. tr. 79–. ISBN 978-90-6611-844-7.
  171. ↑ https://www.gezondheidsnet.nl/medicijnen/meno-implantr%5B%5D
  172. ↑ Bernard A. Eskin (1988). The Menopause: Comprehensive Management. Macmillan. tr. 278. ISBN 978-0-02-334230-1. Estradiol Pellets — (Progynon Pellets® — Progynon Associates), 25 mg (Estropel Pellets® — Bartor Pharmacal).
  173. ↑ American Medical Association. Dept. of Drugs; Council on Drugs (American Medical Association); American Society for Clinical Pharmacology and Therapeutics (1 tháng 2 năm 1977). AMA drug evaluations. Publishing Sciences Group. tr. 561. ISBN 978-0-88416-175-2. Subcutaneous implantation: (Estradiol) One 25 mg pellet every three to four months or two 25 mg pellets every four to six months. Preparations. Progynon (Schering). Implantation: Pellets 25 mg.
  174. ↑ John Morgan Jones (1979). Physicians' Desk Reference. Medical Economics Company. tr. 1508. PROGYNON Pellets for subcutaneous implantation are cylindrical in shape with an approximate diameter of 3.2 mm. and length of 3.5 mm. Each PROGYNON Pellet contains 25 mg. estradiol.
  175. ↑ Martin Birkhauser; David Barlow; Morris Notelovitz; Margaret Rees (12 tháng 8 năm 2005). Health Plan for the Adult Woman: Management Handbook. CRC Press. tr. 27–. ISBN 978-0-203-49009-9.
  176. ↑ Pinkerton JV (tháng 12 năm 2014). “What are the concerns about custom-compounded "bioidentical" hormone therapy?”. Menopause. 21 (12): 1298–300. doi:10.1097/GME.0000000000000376. PMID 25387347.
  177. ↑ Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV (tháng 4 năm 2016). “Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement”. J. Clin. Endocrinol. Metab. 101 (4): 1318–43. doi:10.1210/jc.2016-1271. PMID 27032319.
  178. ↑ Gentile S (tháng 12 năm 2005). “The role of estrogen therapy in postpartum psychiatric disorders: an update”. CNS Spectr. 10 (12): 944–52. doi:10.1017/S1092852900010518. PMID 16344831.
  179. ↑ Ng RC, Hirata CK, Yeung W, Haller E, Finley PR (tháng 9 năm 2010). “Pharmacologic treatment for postpartum depression: a systematic review”. Pharmacotherapy. 30 (9): 928–41. doi:10.1592/phco.30.9.928. PMID 20795848.
  180. ↑ di Scalea TL, Wisner KL (tháng 11 năm 2009). “Pharmacotherapy of postpartum depression”. Expert Opin Pharmacother. 10 (16): 2593–607. doi:10.1517/14656560903277202. PMC 2929691. PMID 19874247.
  181. ↑ Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL (tháng 9 năm 2009). “Transdermal estradiol for postpartum depression: a promising treatment option”. Clin Obstet Gynecol. 52 (3): 516–29. doi:10.1097/GRF.0b013e3181b5a395. PMC 2782667. PMID 19661765.
  182. ↑ Sharma V (tháng 10 năm 2003). “Pharmacotherapy of postpartum psychosis”. Expert Opin Pharmacother. 4 (10): 1651–8. doi:10.1517/14656566.4.10.1651. PMID 14521476.

Tài liệu tham khảo

WikiPedia: Estradiol_(dược_phẩm) http://www.chemspider.com/Chemical-Structure.5554.... http://www.drugs.com/monograph/estradiol.html http://www.ilexmedical.com/files/PDF/Estradiol_ARC... http://www.micromedexsolutions.com http://media.pfizer.com/files/products/uspi_estrin... http://pharmanovia.com/product/estradurin/ http://adisinsight.springer.com/drugs/800038089 http://www.wjpps.com/download/article/1412071798.p... http://www.accessdata.fda.gov/drugsatfda_docs/labe... http://www.accessdata.fda.gov/scripts/cder/daf/